Submitted:
23 January 2026
Posted:
26 January 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Search Strategy
2.2. Inclusion and Exclusion Criteria
2.3. Study Selection and Data Extraction
2.4. Development of the Ultrasound Reporting Completeness Score
2.5. Statistical Analysis
3. Results
3.1. Patient Baseline Characteristics
3.2. Ultrasound Reporting Completeness Score Results
3.3. Summary of Sonographic Features
4. Discussion
5. Conclusions
Disclosure of conflict of interest
Availability of data and materials
References
- Goodman M, Curry T and Russel T. Xanthogranulomatous pyelonephritis (XGP): a local disease with systemic manifestations. Report of 23 patients and review of the literature. Medicine (Baltimore) 1979; 58:171-81.
- Dogan-Ekici AI, Usubütün A, Küçükali T and Ayhan A. Xanthogranulomatous endometritis: a challenging imitator of endometrial carcinoma. Infect Dis ObstetGynecol. 2007; 2007: 34763. [CrossRef]
- Russack V and Lammers RJ. Xanthogranulomatous endometritis. Report of six cases and a proposed mechanism of development. Arch Pathol Lab Med. 1990; 114: 929-32.
- Noack F, Briese J, Stellmacher F, Hornung D and Horny HP. Lethal outcome in xanthogranulomatous endometritis. APMIS. 2006; 114: 386-8. [CrossRef]
- Guerriero S, Condous G, Rolla M, Pedrassani M, Leonardi M, Hudelist G, Ferrero S, Alcazar JL, Ajossa S, Bafort C, Van Schoubroeck D, Bourne T, Van den Bosch T, Singh SS, Abrao MS, Di Giovanni A, Tomassetti C, Timmerman D. Addendum to consensus opinion from the International Deep Endometriosis Analysis (IDEA) group: sonographic evaluation of superficial endometriosis. Ultrasound Obstet Gynecol. 2025; 66: 541-547. [CrossRef]
- Qiu Y, Xie Z, Jiang Y, Ma J. Segment anything with inception module for automated segmentation of endometrium in ultrasound images. J Med Imaging (Bellingham). 2024; 11: 034504. [CrossRef]
- Kim MJ, Lee Y, Lee C, Chun S, Kim A, Kim HY, Lee JY. Accuracy of three dimensional ultrasound and treatment outcomes of intrauterine adhesion in infertile women. Taiwan J Obstet Gynecol. 2015; 54(6):737-41. [CrossRef]
- Barua R, Kirkland JA and Petrucco OM. Xanthogranulomatous endometritis: case report. Pathology. 1978; 10: 161-4. [CrossRef]
- Zhang XS, Dong HY, Zhang LL, Desouki MM and Zhao C. Xanthogranulomatous inflammation of the female genital tract: report of three cases. J Cancer. 2012; 3: 100-106. [CrossRef]
- Wader JV, Jain A, Kumbhar SS and Vhawal V. Histiocytic endometritis. Am J Case Rep. 2013; 14: 329-32. [CrossRef]
- Leone FP, Timmerman D, Bourne T, Valentin L, Epstein E, Goldstein SR, Marret H, Parsons AK, Gull B, Istre O, Sepulveda W, Ferrazzi E, Van den Bosch T. Terms, definitions and measurements to describe the sonographic features of the endometrium and intrauterine lesions: a consensus opinion from the International Endometrial Tumor Analysis (IETA) group. Ultrasound Obstet Gynecol. 2010; 35: 103-12.
- Wu H, Liu J, Chen L, Peng J. Contrast-enhanced Ultrasound of Xanthogranulomatous Endometritis: A Case Report and Literature Review. Curr Med Imaging. 2023 May 11. [CrossRef]
- Shraim S, Al-Ettewi W, Mahfouz IA, Al-Attar M, Al-Masri A. Rare histopathological diagnosis of malakoplakia and Rosai-Dorfman disease in the same uterus mimicking malignancy: A case report. Exp Ther Med. 2025; 29: 44. [CrossRef]
- Batool R, Abdul Wahab NA, Selvamani S, Hennessy G. Recurrent pyometra coupled with xanthogranulomatous endometritis mimicking pyelonephritis and malignancy: unravelling clinical complexities. BMJ Case Rep. 2025;18: e259441. [CrossRef]
- Malik V, Chatterjee D, Goel B, Takkar N. Xanthogranulomatous Endometritis: A Benign Uncommon Masquerader of Malignancy. J Midlife Health. 2019; 10: 206-208. [CrossRef]
- Merviel P, James P, Carlier M, Thomas-Kergastel I, Guilloique M, Conan-Charlet V, Bastard C, Marcorelles P, Jobic Y, Dupré PF. Xanthogranulomatous endometritis: A case report and literature review. Clin Case Rep. 2021; 9: e04299. [CrossRef]
- Burston K, Lim W. Xanthogranulomatous endometritis: A rare histopathological finding. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2021; 61: SUPPL 1 (47-).
- Silva-Rengifo C, Asencio A, Salirrosas O. Xanthogranulomatous Endometritis: A Report of Two Cases. Cureus. 2023; 15: e38226. [CrossRef]
- Na JM, Kim MH, Ko GH, Shin JK. Xanthogranulomatous endometritis: a report of two Korean cases with cytologic findings. J Pathol Transl Med. 2020; 54: 513-516. [CrossRef]
- Makkar M, Gill M, Singh D. Xanthogranulomatous endometritis: an unusual pathological entity mimicking endometrial carcinoma. Ann Med Health Sci Res. 2013; 3(Suppl 1): S48-9. [CrossRef]
- Altanis S, Raweily E, Katesmark M. Xanthogranulomatous endometritis and oophoritis secondary to diverticulitis. A rare cause of postmenopausal bleeding. J Obstet Gynaecol. 2007; 27: 746-7. [CrossRef]
- Du XZ, Lu M, Safneck J, Baker P, Dean E, Mottola J. Xanthogranulomatous endometritis mimicking endometrial carcinoma: A case report and review of literature. Radiol Case Rep. 2018; 14: 121-125. [CrossRef]
- Malik CA, Dudani S, Mani BN. Xanthogranulomatous endometritis presenting as pyometra and mimicking carcinoma on imaging. J Midlife Health. 2016; 7: 88-90. [CrossRef]
- Kumar N, Lakra PS, Sinha RK, Roy AD, Saha D, Sinha JK. Xanthogranulomatous Endometritis with calculus formation in setting of prolapsed uterus. Autops Case Rep. 2023; 13: e2023439. [CrossRef]
- Anandathirtha K, Shabnam Z, Manjeera L, Ramesh N. Xanthogranulomatous endometritis with unilateral salpingo-oophoritis in a postmenopausal woman masquerading as a malignancy. BMJ Case Rep. 2023; 16: e247341. [CrossRef]
- Morales Vicente A, García Sánchez Y, Santonja López N, Gilabert Estellés J. Xanthogranulomatous endometritis. Facts Views Vis Obgyn. 2023; 15: 351-353.

| Assessment Item | Scoring Criteria and Explanations | Score Range |
| Basic Lesion Description | Scoring Rule: Based on the number of the following three information categories described. • A. Uterine Size Abnormality: (e.g., “enlarged uterus” or “bulky uterus”). • B. Lesion Nature (IETA criteria): Mention of any of the following: - Basic Presence (e.g., intrauterine fluid collection/effusion” or “intrauterine mass/occupying lesion”). - Echogenicity Uniformity (e.g., uniform” or “non-uniform/heterogeneous”). - Lesion Texture (e.g., “cystic”, “solid”, or “mixed”). - Echogenicity Level (e.g., “hyperechoic/strong echo”, “isoechoic”, or “hypoechoic/weak echo”. • C. Precise Morphology (IETA criteria): Mention of specific morphological terms (e.g., “nodular”, “mass-like”, “polypoidal”, or “cauliflower like”). 1 point: Contains any 1 of categories A, B, or C. 2 points: Contains any 2 of categories A, B, or C. 3 points: Contains all 3 categories (A, B, and C). |
0-3 |
| Lesion Measurement | Provides specific dimensions of the lesion or uterus (e.g., length, width, thickness, endometrial thickness). 0 points: No specific measurement values provided. 1 point: At least one specific measurement value provided. |
0-1 |
| Endometrium-Myometrium Relationship | Describes the state of the endometrium or the relationship of the lesion to the myometrium/endometrium. 0 points: Not mentioned. 1 point: Explicitly describes relevant features (e.g., “endometrial thickening/irregularity” or “lesion with clear/unclear demarcation from the myometrium”, “lesion involving the myometrium”). |
0-1 |
| Color Doppler Assessment | Mentions the use of Color Doppler and describes blood flow. 0 points: Use of Doppler not mentioned. 1 point: Explicitly mentions the use of CDFI and describes blood flow signals (e.g., “rich vascularity” or “no internal flow”). |
0-1 |
| Spectral Doppler Parameters | Provides hemodynamic parameters. 0 points: No parameters provided. 1 point: Provides RI (Resistive Index) or PI (Pulsatility Index) values. |
0-1 |
| Provision of Ultrasound Images | Whether ultrasound images are provided in the paper for reference. 0 points: No ultrasound images provided. 1 point: At least one ultrasound image provided. |
0-1 |
| Total Score | 0-8 |
| Author (Year) | Basic Lesion Description | Lesion Measurement | Endometrium-Myometrium Relationship | Color Doppler Assessment | Spectral Doppler Parameters | Provision of Ultrasound Images | Total Score |
| Wu et al. (2023) [12] | 2 | 1 | 0 | 1 | 1 | 1 | 6 |
| Noack et al. (2006) [4] | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| Shraim et al. (2025) [13] | 1 | 1 | 1 | 0 | 0 | 0 | 3 |
| Batool et al. (2025) [14] | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| Malik et al. (2019) [15] | 1 | 1 | 1 | 0 | 0 | 1 | 4 |
| Merviel et al. (2021) [16] | 1 | 1 | 1 | 0 | 0 | 1 | 4 |
| Doğan-Ekici et al. (2007) [2] | 1 | 1 | 1 | 0 | 0 | 0 | 3 |
| BURSTON et al. (2021) [17] | 1 | 1 | 1 | 0 | 0 | 0 | 3 |
| Silva-Rengifo et al. (2023) [18] | 1 | 1 | 1 | 1 | 1 | 1 | 6 |
| Na et al. (2020) [19] | 2 | 0 | 0 | 0 | 0 | 0 | 2 |
| Makkar et al. (2013) [20] | 1 | 1 | 1 | 0 | 0 | 0 | 3 |
| Altanis et al. (2007) [21] | 1 | 1 | 1 | 0 | 0 | 0 | 3 |
| Du et al. (2018) [22] | 1 | 0 | 0 | 1 | 0 | 1 | 3 |
| Malik et al. (2016) [23] | 2 | 1 | 1 | 0 | 0 | 0 | 4 |
| Kumar et al. (2023) [24] | 2 | 0 | 1 | 0 | 0 | 0 | 3 |
| Anandathirtha et al. (2023) [25] | 1 | 1 | 0 | 0 | 0 | 0 | 2 |
| Morales et al. (2023) [26] | 1 | 1 | 1 | 0 | 0 | 0 | 3 |
| Zhang et al. (2012) [9] | 1 | 1 | 1 | 0 | 0 | 0 | 3 |
| Sonographic Feature (based on direct description or inferable findings) | Frequency (Based on Total N=18) | Subgroup Distribution Analysis (Within Reports Describing the Category) |
| Uterus Uterine Enlargement |
7 (38.9%) |
|
| Endometrium Endometrial Thickening or Irregularity |
11 (61.1%) |
|
| Intracavitary Lesion – Presence Fluid Collection or Mass |
16 (88.9%) |
|
| Intracavitary Lesion - Characteristics (when specified) Echogenicity Level (n=4) Hyperechoic Hypoechoic Lesion Texture (n=16) Solid Cystic Mixed Uniformity of Echogenicity (n=9) Uniform Heterogeneous |
2 (11.1%) 2 (11.1%) 4 (22.2%) 11 (68.8%) 1 (5.6%) 3 (16.7%) 6 (33.3%) |
(Denominator = reports with specific description) (Denominator = 4) 2 / 4 (50.0%) 2 / 4 (50.0%) (Denominator = 16) 4 / 16 (25.0%) 11 / 16 (68.8%) 1 / 16 (6.3%) (Denominator = 9) 3 / 9 (33.3%) 6 / 9 (66.7%) |
| Intracavitary Lesion - Morphology (when specified) Polypoidal |
1 (5.6%) |
|
| Lesion Measurement Any Measurement Provided |
13 (72.2%) |
|
| Endometrium-Myometrium Relationship |
12 (66.7%) |
|
| Any Color Doppler Assessment Provided Blood Flow Detected No Blood Flow Detected |
3 (16.7%) 2 (11.1%) 1 (5.6%) |
(Denominator = 3) 2 / 3 (66.7%) 1 / 3 (33.3%) |
| Resistive Index Provided Low Resistive Index (RI < 0.7) |
2 (11.1%) 2 (11.1%) |
(Denominator = 2) 2 / 2 (100%) |
| Ultrasound Image Provided | 5 (27.8%) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
